Bio-Rad Announces Agreement in Principle to Acquire MJ Research
02 Juin 2004 - 3:00PM
PR Newswire (US)
Bio-Rad Announces Agreement in Principle to Acquire MJ Research
HERCULES, Calif., June 2 /PRNewswire-FirstCall/ -- Bio-Rad
Laboratories, Inc. (Amex: BIO; BIOb), a multinational manufacturer
and distributor of life science research products and clinical
diagnostics, announced today that it has signed a binding letter
agreement which sets forth certain principal terms for the
acquisition by Bio-Rad of MJ GeneWorks, Inc., and its subsidiaries
for approximately $47 million in cash plus the assumption of
certain liabilities of those companies. MJ GeneWorks is the parent
company of MJ Research, Inc. of Waltham, Massachusetts, a
biotechnology company that specializes in thermal cycling
instrumentation and reagents used to amplify DNA. The acquisition
is subject to completion of a definitive purchase agreement and
necessary government approvals. MJ Research, Inc. is a
biotechnology company specializing in premium instruments and
consumables used in modern biological research. MJ Research
pioneered the use of Peltier-effect technology and has introduced a
number of other innovations in the thermal-cycling field. MJ
Research employs approximately 300 employees. Bio-Rad Laboratories,
Inc. (http://www.bio-rad.com/) is a multinational manufacturer and
distributor of life science research products and clinical
diagnostics. It is based in Hercules, California, and serves more
than 70,000 research and industry customers worldwide through a
network of more than 30 wholly owned subsidiary offices. Various
statements made within this press release may constitute
"forward-looking statements" for purposes of the Securities and
Exchange Commission's "safe harbor" provisions under the Private
Securities Litigation Reform Act of 1995 and Rule 3b-6 under the
Securities Exchange Act of 1934. The forward-looking statements
contained herein involve risks and uncertainties that could cause
results to differ materially from the Company's expectations.
DATASOURCE: Bio-Rad Laboratories, Inc. CONTACT: Christine Tsingos,
Vice President and Chief Financial Officer, or Ron Hutton,
Treasurer, both of Bio-Rad Laboratories, Inc., +1-510-724-7000, or
Web site: http://www.bio-rad.com/
Copyright